Reading is good for you...
Reading about what's good for you is even better.
December 18, 2023
December 14, 2023
August 8, 2022
Get your Cosentyx delivered at your door for FREE
Cosentyx (Secukinumab) belongs to the class of medications called biological response modifiers ("biologics"). Cosentyx (Secukinumab) is used to treat moderate-to-severe plaque psoriasis in adults whose specialists have determined that systemic or phototherapy may be beneficial.
We accept all insurance plan
**Actual price will depend on the insurance coverage in your province
Cosentyx (Secukinumab) belongs to the class of medications called biological response modifiers ("biologics").
Cosentyx (Secukinumab) is used to treat moderate-to-severe plaque psoriasis in adults whose specialists have determined that systemic or phototherapy may be beneficial. It is also used to treat active Psoriatic Arthritis and active ankylosing spondylitis in adults who have not had an adequate response to other treatments.
For people with plaque psoriasis, psoriatic arthritis or ankylosing spondylitis, the body overproduces a protein called interleukin-17A (IL-17A). Cosentyx (Secukinumab) recognizes this protein and blocks the action of IL-17A, reducing the symptoms of these conditions.
Cosentyx (Secukinumab) may be available under multiple brand names and/or in several different forms. Any specific brand name of Cosentyx (Secukinumab) may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of Cosentyx (Secukinumab) may not be used for all of the conditions discussed here.
Your doctor may have suggested Cosentyx (Secukinumab) for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking Cosentyx (Secukinumab), speak to your doctor. Do not stop taking Cosentyx (Secukinumab) without consulting your doctor.
Do not give Cosentyx (Secukinumab) to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take Cosentyx (Secukinumab) if their doctor has not prescribed it.
Plaque psoriasis: The recommended starting dose of Cosentyx (Secukinumab) is 300 mg injected subcutaneously (under the skin), once a week for 4 weeks. After the first 4 weeks, 300 mg is injected once a month. Each dose is given as 2 injections of 150 mg.
Psoriatic arthritis: The recommended starting dose of Cosentyx (Secukinumab) is 150 mg injected subcutaneously (under the skin), once a week for 4 weeks. After the first 4 weeks, 150 mg is injected once a month. In certain situations, a dose of 300 mg may be required.
Anklyosing spondylitis: The recommended starting dose of Cosentyx (Secukinumab) is 150 mg injected subcutaneously (under the skin), once a week for 4 weeks. After the first 4 weeks, 150 mg is injected once a month.
Cosentyx (Secukinumab) is administered by subcutaneous injection in the thigh, buttocks, or abdomen. It is important to rotate the site of injection in order to minimize the risk of fat wasting at the site of injection. If possible, avoid injecting into areas that are affected by psoriasis.
Do not shake Cosentyx (Secukinumab) before using it. The solution for injection should be clear and colourless-to-slightly-yellow. If it is brown or you can see particles in the solution, do not use it.
If you are using Cosentyx (Secukinumab) at home, your doctor will ensure that you understand exactly how to use it. Make sure you ask any and all questions necessary to ensure that you use it exactly as prescribed. Please refer to the appropriate package insert for details on how to mix the medicine and for proper injection procedures. It is important to visit your doctor regularly during therapy to ensure that the medication is working safely and effectively.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
It is important to use Cosentyx (Secukinumab) exactly as prescribed by your doctor.
If you miss a dose, take it as soon as possible and contact your doctor to discuss when you should inject the next dose. Do not take a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.
Store Cosentyx (Secukinumab) in the refrigerator, protect it from light and moisture, and keep it out of the reach of children. Do not allow Cosentyx (Secukinumab) to freeze.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Cosentyx (Secukinumab). If you are concerned about side effects, discuss the risks and benefits of Cosentyx (Secukinumab) with your doctor.
The following side effects have been reported by at least 1% of people taking Cosentyx (Secukinumab). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Cosentyx (Secukinumab).
Each 1 mL of sterile solution for subcutaneous injection contains 150 mg of Cosentyx (Secukinumab). Nonmedicinal ingredients: trehalose dehydrate, L-histidine/histidine hydrochloride monohydrate, L-methionine, polysorbate 80, and water for injection.
Cosentyx (Secukinumab) is supplied as a sterile solution in a single-use, prefilled SensoReady pen with a 27-gauge fixed ½-inch needle or a single-use, prefilled syringe with a 27-gauge fixed ½-inch needle.
Do not take Cosentyx (Secukinumab) if you are allergic to Cosentyx (Secukinumab) or any ingredients of the medication.
There may be an interaction between Cosentyx (Secukinumab) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Cosentyx (Secukinumab). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Cosentyx (Secukinumab).
Allergic reactions: In rare cases, some people may develop an allergic reaction to Cosentyx (Secukinumab). Signs of an allergic reaction include a severe rash, Hives, swollen face or throat, or difficulty breathing. If these occur, contact your doctor immediately.
Inflammatory bowel disease: If you have inflammatory bowel disease, Cosentyx (Secukinumab) may make symptoms of your condition worse. Discuss with your doctor how Cosentyx (Secukinumab) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Cosentyx (Secukinumab), and whether any special monitoring is needed.
Infections: Cosentyx (Secukinumab) can increase the risk of developing an infection, including serious infections such as sepsis, pneumonia, and Tuberculosis. Before starting Cosentyx (Secukinumab) treatment, your doctor may test to see if you have tuberculosis. If you notice signs of an infection such as fever, chills, pain, swelling, coughing, or pus, contact your doctor as soon as possible. Cosentyx (Secukinumab) should also not be started while you have an active infection.
Tell your doctor if you have a history of infections that keep coming back, or other conditions that might increase your risk of infections such as Diabetes. While you are taking Cosentyx (Secukinumab), your doctor will monitor you for signs of infection.
Latex allergy: The removable cap of the pre-filled syringe and SensoReady pen contains a chemical similar to natural rubber latex. No studies have been done with people who are allergic or sensitive to latex. If you have a latex allergy, discuss the risks and benefits of using this product, with your doctor.
Vaccines: Live vaccines (e.g., BCG, yellow fever) are not recommended for people taking Cosentyx (Secukinumab). Talk to your doctor if you need any vaccinations while taking Cosentyx (Secukinumab).
Pregnancy: Cosentyx (Secukinumab) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Cosentyx (Secukinumab), contact your doctor immediately.
Breast-feeding: It is not known Cosentyx (Secukinumab) passes into breast milk. If you are a breast-feeding mother and are taking Cosentyx (Secukinumab), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Cosentyx (Secukinumab) have not been established for children.
All material © 1996-2021 MediResource Inc. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition.
December 18, 2023
December 14, 2023
August 8, 2022